NCT01498081 - A Single-dose Study to Investigate the Effects of 3 Different Doses of Inhaled AZD2115 in COPD Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions

COPD

Interventions

DRUG

AZD2115

AZD2115 administered via inhalation

DRUG

Placebo

Placebo administered via inhalation

DRUG

Indacaterol

Indacaterol administered via inhalation

DRUG

Indacaterol + Tiotropium

Indacaterol + Tiotropium administered inhalation

Trial Locations (6)

Research Site, Bialystok

Research Site, Lodz

Research Site, Proszowice

Research Site, Łęczna

Research Site, Gothenburg

Research Site, Lund